NCT02315495View on ClinicalTrials.gov

Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 3, 2015

Primary Completion Date

August 26, 2016

Study Completion Date

August 26, 2016

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

DRUG

Acarbose

Trial Locations (1)

Unknown

Department of Endocrinology, Zhongda Hospital. Institute of Diabetes, Southeast University, Nanjing

All Listed Sponsors
lead

Zilin Sun

OTHER

NCT02315495 - Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes | Biotech Hunter | Biotech Hunter